Bylaws

The IACH initiative was launched by an international group of physicians whose focus is to promote good clinical practice in the field of clinical hematology.

There is a growing and urgent global demand for academic continuing education of hematologists comprising clinical skills for patient management, standardization of real-life treatment procedures, as well in the performance of routine and comprehensive care in the various fields of hematology.

Currently, hematology is likely the most dynamic medical specialty with respect to new pathophysiology findings and their implementation in new therapies. The development of new drugs (targeted therapies, immunotherapy, etc.) is accompanied by a growing demand for sharing experiences in order to improve the quality of patient treatment and care through the development of professional competencies and excellence. In order to attain these objectives, cooperation is needed between health professionals worldwide under a common umbrella to promote health care capacities by sharing scientific and clinical knowledge, methods and skills.

The IACH aims to create a comprehensive intellectual and operational environment for acquisition of knowledge, skills, clinical judgement, and attitudes essential for the practice of clinical hematology.

The IACH initiative is managed by an executive committee and scientific steering committee.

Executive committee (2020-2025):
Pr Mohamad Mohty, Chair
Pr Arnon Nagler, Vice-chair
Pr Bipin Savani, Secretary
Pr Ali Bazarbachi, Secretary
Pr Bhagirathbhai Dholaria, Vice-secretary

Scientific steering committee (2020-2025):
Pr Ali Bazarbachi (Lebanon; Special Webinars, Middle-East)
Pr Didier Blaise (France; Special Webinars)
Dr Eolia Brissot (France; Post-Congress webinars)
Pr Thierry Facon (France; COMy congress)
Pr Norbert-Claude Gorin (France; Special Webinars Asia)
Pr He Huang (China; Special Webinars Asia)
Pr Florent Malard (France; Junior Club)
Pr Junia Melo (Australia; Clin Hemat Int)
Pr Mohamad Mohty (France; Journal Club)
Pr Arnon Nagler (Israel; IACH News)
Pr Naveen Pemmaraju (USA; MPNCo&D congress)
Dr Zinaida Peric (Croatia; Special Webinars)
Pr Bipin Savani (USA; Innovation webinars)
Pr Anna Sureda (Spain; COLYM congress)
Pr Amer Zeidan (USA; COMydAL congress)
Pr Bhagirathbhai Dholaria (Nursing webinars)
Dr. Katie Gatwood (Pharmacists’ webinars)

All IACH members, friends and supporters have the opportunity to indicate their interest to join and/or contribute to the different

scientific activities. If you have questions, please send a request to: [email protected]

Administrative management: C/O CME Congresses Ltd.

The INTERNATIONAL ACADEMY FOR CLINICAL HEMATOLOGY is registered in England under Number: 14200227 under the Companies Act 2006.i

Extract of the MEMORANDUM AND ARTICLES OF ASSOCIATION

3 Objects

3.1 The company’s objects shall be as follows:

3.1.1 to promote education, sharing of knowledge, expertise, and good clinical practice in the broader field of clinical hematology, oncology and cancer in general;

3.1.2 the development of skills and training of all stakeholders for patient management;

3.1.3 standardisation of real-life treatment procedures for routine and comprehensive care in the various fields of haematology, oncology and cancer;

3.1.4 facilitating the sharing of experiences by healthcare professionals in order to improve the quality of patient treatment and care through the development of professional competencies and excellence;

3.1.5 creating a comprehensive intellectual and operational environment and a global network of experts for the acquisition of knowledge, skills, clinical judgment, and attitudes essential for the practice of clinical hematology, oncology and cancer in general; and

3.1.6 collaborating and assisting all interested stakeholders towards the development of novel treatment approaches in clinical haematology, oncology and cancer in general.

3.2 In the furtherance of the above objects the company shall not by run and managed with a view to making a profit, but shall instead apply its income in the furtherance of the objects as determined by the directors and the members in accordance with the articles.